Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 25, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

Intraprostatic targeting.

Osamu Ukimura1, Kenneth Faber, Inderbir S Gill

  • 1USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA. ukimura@usc.edu

Current Opinion in Urology
|January 18, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective study.

Urologic oncology·2021
Same author

Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.

European urology focus·2020
Same author

Renal cancer with extensive level IV intracardiac tumour thrombus removed by robot.

Lancet (London, England)·2020
Same author

Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer.

BJU international·2020
Same author

Timing, Patterns and Predictors of 90-Day Readmission Rate after Robotic Radical Cystectomy.

The Journal of urology·2020
Same author

Web search queries and prostate cancer.

The Lancet. Oncology·2020

Emerging technologies enhance prostate cancer detection and targeting. Advanced imaging and digital mapping improve localization and characterization of clinically significant prostate cancer for better management.

Area of Science:

  • Urology
  • Medical Imaging
  • Oncology

Background:

  • Conventional prostate biopsy techniques lead to overdiagnosis of insignificant cancer and underdiagnosis of significant cancer.
  • Active surveillance and focal therapy are increasingly important for managing low-risk prostate cancer.
  • Accurate localization and targeting of prostate cancer are crucial for effective management.

Purpose of the Study:

  • To review emerging technologies for enhanced visualization and precise targeting of prostate cancer.
  • To discuss advancements in imaging and mapping techniques for prostate cancer management.

Main Methods:

  • Review of emerging ultrasound and MRI modalities for improved tumor visualization and characterization.
  • Description of digital mapping techniques for three-dimensional biopsy trajectory mapping.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Related Experiment Videos

Last Updated: May 25, 2026

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

  • Discussion of molecular or cancer-specific targeting approaches.

    • Main Results:

    • Emerging ultrasound and MRI techniques enhance prostate cancer visualization and characterization.
    • Digital mapping allows for precise 3D mapping of biopsy-proven cancer lesions.
    • Molecular targeting shows promise for cellular-level imaging and therapy.

    Conclusions:

    • Emerging technologies improve the identification of clinically relevant prostate cancer through multiparametric imaging.
    • Digitalized imaging enhances the ability to precisely target identified prostate cancer.
    • These advancements support more accurate staging and intervention for prostate cancer.